Other Species / Isoforms
  PLCL1 (mouse)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
S48-p
GRMRDRRsGVALPGA
0 6
PLCL1 (human) GRMRDRRsGVALPGA S47-p
PLCL1 (mouse) GRMRDRRsGVALPGA S48-p
PLCL1 (rat) GRMRDRRsGVALPGN S48-p
S62
AAGVPADSEAGLLEA
0 1
PLCL1 (human) AAGTPADsEAGLLEA S61-p
PLCL1 (mouse) AAGVPADSEAGLLEA S62
PLCL1 (rat) NAGVPADSEAGLLEA S62
T73-p
LLEAARAtPRRSsII
0 3
PLCL1 (human) LLEAARAtPRRSsII T72-p
PLCL1 (mouse) LLEAARAtPRRSsII T73-p
PLCL1 (rat) LLEAARATPRRTSII T73
S78-p
RAtPRRSsIIKDPSN
0 5
PLCL1 (human) RAtPRRSsIIKDPSN S77-p
PLCL1 (mouse) RAtPRRSsIIKDPSN S78-p
PLCL1 (rat) RATPRRTSIIKDPSN S78
T94-p
KCGGRKKtVsFSSMP
Upstream
Downstream
1 12
Effects on Modified Protein
  • molecular association, regulation
Kinase, in vitro:
  • PKACA (mouse)
Treatment
  • colforsin
  • insulin
  • LY294002
  • MK-2206
view more >
PLCL1 (human) KCGGRKKtVsFSsMP T93-p
PLCL1 (mouse) KCGGRKKtVsFSSMP T94-p
PLCL1 (rat) KCGGRKKtVsFSSMP T94-p
S96-p
GGRKKtVsFSSMPSE
Upstream
1 17
Kinase, in vitro:
  • PKACA (mouse)
Treatment
  • insulin
  • LY294002
  • MK-2206
view more >
PLCL1 (human) GGRKKtVsFSsMPSE S95-p
PLCL1 (mouse) GGRKKtVsFSSMPSE S96-p
PLCL1 (rat) GGRKKtVsFSSMPSE S96-p
S99
KKtVsFSSMPSEKKI
0 1
PLCL1 (human) KKtVsFSsMPSEKKI S98-p
PLCL1 (mouse) KKtVsFSSMPSEKKI S99
PLCL1 (rat) KKtVsFSSMPSEKKI S99
Y132
VRPNSRIYNRFFTLD
0 1
PLCL1 (human) VRPNSRIyNRFFTLD Y131-p
PLCL1 (mouse) VRPNSRIYNRFFTLD Y132
PLCL1 (rat) VRPNSRIYNRFFTLD Y132
T247
PRFMWLKTVFEAADV
1 0
PLCL1 (human) PRFMWLKtVFEAADV T246-p
PLCL1 (mouse) PRFMWLKTVFEAADV T247
PLCL1 (rat) PRFMWLKTVFEAADV T247
Y432
GPADINGYVRALKMG
0 1
PLCL1 (human) GPADINGyIRALKMG Y431-p
PLCL1 (mouse) GPADINGYVRALKMG Y432
PLCL1 (rat) GPADINGYVRALKMG Y432
K533-ub
SYLPSPEkLKNMIIV
0 1
PLCL1 (human) SYLPSPEKLKRMIIV K532
PLCL1 (mouse) SYLPSPEkLKNMIIV K533-ub
PLCL1 (rat) SYLPSPEKLKHMIIV K533
S547-p
VKGKKLPsEsDLLEG
0 1
PLCL1 (human) VKGKKLPSDPDVLEG S546
PLCL1 (mouse) VKGKKLPsEsDLLEG S547-p
PLCL1 (rat) VKGKKLPSESDLLEG S547
S549-p
GKKLPsEsDLLEGEV
0 2
PLCL1 (human) GKKLPSDPDVLEGEV P548
PLCL1 (mouse) GKKLPsEsDLLEGEV S549-p
PLCL1 (rat) GKKLPSESDLLEGEV S549
T557-p
DLLEGEVtDEDEEAE
0 41
PLCL1 (human) DVLEGEVtDEDEEAE T556-p
PLCL1 (mouse) DLLEGEVtDEDEEAE T557-p
PLCL1 (rat) DLLEGEVtDEDEEAE T557-p
S570-p
AEMSRRMsGDYNGEQ
Upstream
0 14
Treatment
  • insulin
  • LY294002
PLCL1 (human) AEMSRRMsVDyNGEQ S569-p
PLCL1 (mouse) AEMSRRMsGDYNGEQ S570-p
PLCL1 (rat) AEMSRRVsGDYNGEQ S570-p
Y573
SRRMsGDYNGEQKHI
0 3
PLCL1 (human) SRRMsVDyNGEQKQI Y572-p
PLCL1 (mouse) SRRMsGDYNGEQKHI Y573
PLCL1 (rat) SRRVsGDYNGEQKHI Y573
H598
SICKSVQHRDFELSM
0 1
PLCL1 (human) SICKSVQyRDFELSM Y597-p
PLCL1 (mouse) SICKSVQHRDFELSM H598
PLCL1 (rat) SICKSVQYRDFELSM Y598
Y635
YPEDFVNYNKKFLSR
0 1
PLCL1 (human) YPEDFVNyNKKFLSR Y634-p
PLCL1 (mouse) YPEDFVNYNKKFLSR Y635
PLCL1 (rat) YPEDFVNYNKKFLSR Y635
S861
GGKPQKRSLSVRMGK
0 2
PLCL1 (human) GGKAQKRsLsVRMGK S860-p
PLCL1 (mouse) GGKPQKRSLSVRMGK S861
PLCL1 (rat) GGKAQKRsLsVRMGK S861-p
S863
KPQKRSLSVRMGKKV
0 2
PLCL1 (human) KAQKRsLsVRMGKKV S862-p
PLCL1 (mouse) KPQKRSLSVRMGKKV S863
PLCL1 (rat) KAQKRsLsVRMGKKV S863-p
Y873
MGKKVREYTMLRNIG
0 1
PLCL1 (human) MGKKVREyTMLRNIG Y872-p
PLCL1 (mouse) MGKKVREYTMLRNIG Y873
PLCL1 (rat) MGKKVREYTMLRNIG Y873
K966-ub
GAIPDVQkRMLAAYD
0 1
PLCL1 (human) GAIPDVQKKMLTAYD K965
PLCL1 (mouse) GAIPDVQkRMLAAYD K966-ub
PLCL1 (rat) GTIPDVQKRMLAAYD K966
S1080-p
SEAKGKRsLEAIEEK
0 3
PLCL1 (human) AEAKSKRsLEAIEEK S1079-p
PLCL1 (mouse) SEAKGKRsLEAIEEK S1080-p
PLCL1 (rat) AEAKGKRsLEAIEEK S1080-p
S1089
EAIEEKESSEENGKL
0 1
PLCL1 (human) EAIEEKEssEENGKL S1088-p
PLCL1 (mouse) EAIEEKESSEENGKL S1089
PLCL1 (rat) EAIEEKESSEENGKL S1089
S1090
AIEEKESSEENGKL_
0 1
PLCL1 (human) AIEEKEssEENGKL_ S1089-p
PLCL1 (mouse) AIEEKESSEENGKL_ S1090
PLCL1 (rat) AIEEKESSEENGKL_ S1090